Triple negative breast cancer: Do we now have something to be positive about?
Androgen receptor blockade
Date
09 Oct 2016Session
Triple negative breast cancer: Do we now have something to be positive about?Presenters
Hervé BonnefoiAuthors
H. BonnefoiAuthor affiliations
- Institute Bergonié, 33076 - Bordeaux/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction: The current landscape
Presenter: Elzbieta Senkus-Konefka
Session: Triple negative breast cancer: Do we now have something to be positive about?
Resources:
Slides
Molecular “dissection” of TNBC to identify therapeutic targets
Presenter: Fabrice André
Session: Triple negative breast cancer: Do we now have something to be positive about?
Resources:
Slides
Immunotherapeutic approaches
Presenter: Peter Schmid
Session: Triple negative breast cancer: Do we now have something to be positive about?
Resources:
Slides